Cellectar Biosciences, Inc.
CLRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001279704
No open-market purchases or sales by Cellectar Biosciences, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $9.08M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Cellectar Biosciences, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 45 | 37 | −8 |
| Shares | 9.13M | 11.6M | +2.46M (+27.0%) |
| Value | $36.3M | $28.3M | −$8.08M (−22.2%) |
New holders (5)
Institutions that held Cellectar Biosciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| JPMorgan Chase & Co | 51,115 | $127.8K | 0.00% |
| Millennium Management LLC | 42,647 | $106.6K | 0.00% |
| Goldman Sachs Group Inc | 35,000 | $87.5K | 0.00% |
| Verition Fund Management LLC | 15,217 | $38.0K | 0.00% |
| Redwood Wealth Management Group, LLC | 1,000 | $2.50K | 0.00% |
Sold out (13)
Institutions that held Cellectar Biosciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Lighthouse Investment Partners, LLC | 138,761 | $552.3K |
| Renaissance Technologies LLC | 98,500 | $392.0K |
| GWM Advisors LLC | 44,643 | $177.7K |
| Raymond James & Associates | 36,025 | $143.4K |
| Two Sigma Investments, LP | 20,231 | $80.5K |
| Omers Administration Corp | 18,000 | $71.6K |
| Squarepoint Ops LLC | 17,957 | $71.5K |
| Two Sigma Advisers, LP | 13,400 | $53.3K |
| Belvedere Trading LLC | 3,778 | $15.0K |
| Royal Bank of Canada | 2,500 | $10.0K |
| ICA Group Wealth Management, LLC | 350 | $1.39K |
| The PNC Financial Services Group, Inc. | 300 | $1.19K |
| Wells Fargo & Company | 205 | $816 |